𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Overexpression of plasminogen activator inhibitor type-1 in senescent fibroblasts from normal subjects and those with Werner syndrome

✍ Scribed by Dr. Samuel Goldstein; Elena J. Moerman; Satoshi Fujii; Burton E. Sobel

Book ID
102886442
Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
990 KB
Volume
161
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.

✦ Synopsis

We previously reported that plasminogen activator inhibitor type-1 (PAI-1) mRNA was present at higher steady-state levels in prematurely senescent fibroblasts derived from a subject with Werner syndrome (WS) compared to early passage

πŸ“œ SIMILAR VOLUMES

Increased transcription and modified gro
Increased transcription and modified growth state-dependent expression of the plasminogen activator inhibitor type-1 gene characterize the senescent phenotype in human diploid fibroblasts
✍ Xiao-Chun Mu; Lisa Staiano-Coico; Paul J. Higgins πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 268 KB πŸ‘ 2 views

The type-1 inhibitor of plasminogen activator (PAI-1) is a major physiologic regulator of pericellular proteolytic activity and, as such, influences matrix integrity, cell-to-substrate adhesion, and cellular proliferation. Excessive accumulation of both PAI-1 mRNA and protein correlates with the pro

The 4G/5G polymorphism of the type 1 pla
The 4G/5G polymorphism of the type 1 plasminogen activator inhibitor gene and thrombosis in patients with antiphospholipid syndrome
✍ Dolors TΓ ssies; Gerard Espinosa; Francisco Jose MuΓ±oz-RodrΓ­guez; Carolina Freire πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 99 KB πŸ‘ 1 views

## Objective: To investigate the relationship between the 4g/5g polymorphism of the type 1 plasminogen activator inhibitor (pai-1) gene and thrombotic manifestations in patients with antiphospholipid syndrome (aps). ## Methods: We studied a total of 247 patients included in the following 4 groups